NCT00387933 2015-10-14Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant GliomaDuke UniversityPhase 1 Completed37 enrolled
NCT00154375 2011-04-26Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive GlioblastomaNovartisPhase 3 Completed240 enrolled 8 charts